Tesamorelin 20 mg – GH–Releasing Hormone Analogue

Sale!

Tesamorelin 20 mg – GH–Releasing Hormone Analogue

Original price was: R2 799,99.Current price is: R2 499,99.

Tesamorelin 20mg is a growth hormone support peptide used to stimulate natural GH release, increase IGF-1 activity, and support changes in visceral fat and body composition. It is suited to those who want stronger GH-axis support, improved metabolic signaling, and a more advanced option for abdominal fat and recovery-focused protocols. Supplied as a 20 mg cartridge in 3 mL, it provides a structured pen-based format for evening use.

Dosage scale with pen

15 units 1.00mg 25 units 1.67mg
20 units 1.33mg 30 units 2.00mg

Timing: Evening use
Meal timing: Administer on an empty stomach, approximately 90 minutes after the last meal
Cycle guidance: Use for up to 26 weeks, then rest for 4 weeks before repeating
GH pulse duration triggered: 3–4 hours

Description

How It Works

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH). It acts on the pituitary to stimulate natural pulsatile growth hormone release, which then supports downstream IGF-1 activity. This makes it relevant for protocols focused on visceral fat, metabolic support, body composition, and broader GH-axis support.

Tesamorelin is generally chosen where the goal is stronger endogenous growth hormone signaling rather than direct hormone replacement. In practical use, it is often positioned as a more advanced option for abdominal-fat focused protocols, metabolic support, and recovery-aligned body composition planning.

Dosage Protocol

Growth hormone support: 1.00 – 2.00mg.
Advanced visceral fat / body composition support: 2.00mg.

Notes:
• Evening use on an empty stomach.
• Administer approximately 90 minutes after the last meal.

Cycle length: Use daily for up to 26 weeks, then reassess before continuing.

Each cartridge contains 3mL bacteriostatic water (300 units)

KEEP REFRIGERATED.

Expected Outcomes

Tesamorelin 20mg is typically used where the goal is stronger GH-axis support, improved IGF-1 signalling, and better support for visceral fat and body composition goals.

  • Stronger endogenous growth hormone signalling
  • Improved IGF-1 activity
  • Support for reduction in abdominal visceral fat
  • Improved metabolic support
  • Better alignment with body-composition focused protocols
  • Support for recovery-focused planning

Cautions and Warnings

Not suitable for people under the age of 18.
Not suitable during pregnancy.
Not suitable while breastfeeding.

Related Products

  • Ipamorelin 5mg — GH secretagogue pairing
  • CJC-1295 — complementary GH-pathway support
  • Sermorelin — alternative GHRH analogue option
  • BPC-157 & TB-500 — recovery and tissue-support pairing
  • MOTS-c — metabolic support pairing